Hindsight · review build · data not yet validated

Gene editing revenue

ARK Invest, Big Ideas, 2023, published 2023-01-31

ARK's base case forecast for gene editing revenue is ~$30 billion, though approvals for diseases like Type 1 diabetes could scale the category to $60 billion by 2030.

Source

Verdict

Not graded yet.

All captured fields

idea: Precision Therapies
target year: 2030
metric: annual gene editing revenue (base case)
value: 30
unit: USD billion
subject: Gene editing revenue
page: 80
confidence: high
note: High case USD 60 billion by 2030.